Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedFeb 10, 2025
DataAggregated Company Financials
Companies5
  • 7D-0.5%
  • 3M-12.7%
  • 1Y-8.8%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 3.0%, driven by Genmab declining 2.8%. The industry has fallen 9.5% in the last year. Looking forward, earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 10 Feb 2025DKK 153.8bDKK 26.0bDKK 4.7b15.5x32.8x5.9x
Wed, 08 Jan 2025DKK 168.0bDKK 26.0bDKK 4.7b17.8x35.8x6.5x
Fri, 06 Dec 2024DKK 167.9bDKK 26.0bDKK 4.7b17.2x35.8x6.5x
Sun, 03 Nov 2024DKK 175.7bDKK 25.5bDKK 5.5b20.9x32.1x6.9x
Tue, 01 Oct 2024DKK 179.6bDKK 25.5bDKK 5.5b22.1x32.8x7x
Thu, 29 Aug 2024DKK 201.2bDKK 25.5bDKK 5.5b25.3x36.8x7.9x
Sat, 27 Jul 2024DKK 201.2bDKK 24.8bDKK 5.6b18.4x35.7x8.1x
Mon, 24 Jun 2024DKK 176.3bDKK 24.8bDKK 5.6b16.7x31.3x7.1x
Wed, 22 May 2024DKK 182.2bDKK 24.8bDKK 5.6b18.7x32.4x7.3x
Fri, 19 Apr 2024DKK 178.8bDKK 23.9bDKK 5.0b18.8x35.5x7.5x
Sun, 17 Mar 2024DKK 190.0bDKK 23.9bDKK 5.0b19.6x37.8x7.9x
Tue, 13 Feb 2024DKK 168.2bDKK 23.3bDKK 4.2b23.2x40.4x7.2x
Thu, 11 Jan 2024DKK 182.4bDKK 23.3bDKK 4.2b26.1x43.8x7.8x
Sat, 09 Dec 2023DKK 182.3bDKK 23.3bDKK 4.2b26.3x43.8x7.8x
Mon, 06 Nov 2023DKK 161.8bDKK 22.0bDKK 4.7b19.2x34.1x7.3x
Wed, 04 Oct 2023DKK 190.2bDKK 22.0bDKK 4.7b22.2x40.2x8.6x
Fri, 01 Sep 2023DKK 199.9bDKK 22.0bDKK 4.7b23.7x42.3x9.1x
Sun, 30 Jul 2023DKK 201.6bDKK 19.5bDKK 4.4b35.3x45.8x10.3x
Tue, 27 Jun 2023DKK 201.2bDKK 19.5bDKK 4.4b41.8x45.7x10.3x
Thu, 25 May 2023DKK 216.5bDKK 19.5bDKK 4.4b43.2x49.1x11.1x
Sat, 22 Apr 2023DKK 210.8bDKK 17.9bDKK 3.5b32.9x59.6x11.8x
Mon, 20 Mar 2023DKK 190.4bDKK 17.9bDKK 3.5b29.7x53.7x10.6x
Wed, 15 Feb 2023DKK 206.7bDKK 14.7bDKK 3.3b31.6x63.2x14x
Fri, 13 Jan 2023DKK 206.7bDKK 14.7bDKK 3.3b31.7x63.2x14x
Sun, 11 Dec 2022DKK 236.0bDKK 14.7bDKK 3.3b37.1x72.1x16x
Tue, 08 Nov 2022DKK 218.7bDKK 12.4bDKK 1.5b48.3x144x17.6x
Thu, 06 Oct 2022DKK 197.6bDKK 12.4bDKK 1.5b43.8x130.1x15.9x
Sat, 03 Sep 2022DKK 198.1bDKK 12.4bDKK 1.5b43.8x133.1x16x
Mon, 01 Aug 2022DKK 201.5bDKK 11.1bDKK 130.5m71.3x1544.2x18.2x
Wed, 29 Jun 2022DKK 167.4bDKK 11.1bDKK 130.5m61.7x1282.9x15.1x
Fri, 27 May 2022DKK 157.1bDKK 11.0b-DKK 88,588,000.0058.2x-1773.8x14.2x
Sun, 24 Apr 2022DKK 181.1bDKK 10.7bDKK 622.4m55.2x291x16.9x
Tue, 22 Mar 2022DKK 176.0bDKK 10.7bDKK 625.7m53x281.3x16.4x
Thu, 17 Feb 2022DKK 164.3bDKK 9.8bDKK 117.9m50.8x1393.3x16.7x
Price to Earnings Ratio

1393.3x


Total Market Cap: DKK 164.3bTotal Earnings: DKK 117.9mTotal Revenue: DKK 9.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 113.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 32.8x which is lower than its 3-year average PE of 114x.
  • The 3-year average PS ratio of 10.8x is higher than the industry's current PS ratio of 5.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have grown 241% per year over the last three years.
  • Revenues for these companies have grown 38% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Danish Biotech compare with similar industries?

DK Market2.75%
Healthcare2.56%
Biotech-0.49%
Biotech-0.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 728.503.0%
+DKK 1.5b
50.2%PS669.5x
BIOPOR BioPortoDKK 1.552.9%
+DKK 18.9m
-28.3%PS19.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.